TY - JOUR
T1 - Epigallocatechin-3-O-gallate induces acid sphingomyelinase activation through activation of phospholipase C
AU - Bae, Jaehoon
AU - Kumazoe, Motofumi
AU - Takeuchi, Chieri
AU - Hidaka, Shiori
AU - Fujimura, Yoshinori
AU - Tachibana, Hirofumi
N1 - Funding Information:
This work was supported in part by JSPS KAKENHI grant 22228002 and JPN 15H02448 to H Tachibana and was also supported in part by a Grant-in-Aid for JSPS KAKENHI grant JPN 15K18821 , Kowa Life Science Foundation and Yokoyama Foundation for Clinical Pharmacology . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We appreciate the technical support from the Research Support Center, Graduate School of Kyushu University. The authors would like to thank Enago ( www.enago.jp ) for the English language review.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/11/26
Y1 - 2019/11/26
N2 - Epigallocatechin-3-O-gallate (EGCG)-induced cyclic guanosine monophosphate (cGMP) plays a crucial role in EGCG-induced cell death in various types of cancer cells. However, little is known regarding the early molecular events after cGMP induction. In this study, we showed that cGMP induction is sufficient to induce the phosphorylation of protein kinase C delta (PKCδ) at Ser664, the crucial kinase for EGCG-induced activation of acid sphingomyelinase (ASM). Using a chemical inhibitor library, we revealed that the inhibitors of the negative regulators of diacylglycerol strongly increase the effect of EGCG. We also showed that EGCG treatment increased phospholipase C (PLC) activity, and the same results were obtained with cGMP inducer treatment. EGCG-induced ASM activation was completely suppressed by pharmacological inhibition of PLC. Collectively, EGCG-induced cGMP activated the cGMP/PLC/PKCδ/ASM signaling axis in multiple myeloma cells.
AB - Epigallocatechin-3-O-gallate (EGCG)-induced cyclic guanosine monophosphate (cGMP) plays a crucial role in EGCG-induced cell death in various types of cancer cells. However, little is known regarding the early molecular events after cGMP induction. In this study, we showed that cGMP induction is sufficient to induce the phosphorylation of protein kinase C delta (PKCδ) at Ser664, the crucial kinase for EGCG-induced activation of acid sphingomyelinase (ASM). Using a chemical inhibitor library, we revealed that the inhibitors of the negative regulators of diacylglycerol strongly increase the effect of EGCG. We also showed that EGCG treatment increased phospholipase C (PLC) activity, and the same results were obtained with cGMP inducer treatment. EGCG-induced ASM activation was completely suppressed by pharmacological inhibition of PLC. Collectively, EGCG-induced cGMP activated the cGMP/PLC/PKCδ/ASM signaling axis in multiple myeloma cells.
UR - http://www.scopus.com/inward/record.url?scp=85072722073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072722073&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2019.09.102
DO - 10.1016/j.bbrc.2019.09.102
M3 - Article
C2 - 31585731
AN - SCOPUS:85072722073
SN - 0006-291X
VL - 520
SP - 186
EP - 191
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -
